Pharmaceutical and biotechnology major Wockhardt has reportedly decided to recall over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer, in the US market. The company is recalling these drugs due to deviations in current good manufacturing practice norms laid down by the American health regulator. The recalls have been classified as 'Class-II' by the FDA, which is defined as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. All the drugs being recalled by the company have been manufactured at its Mumbai-based facility and distributed in the US by its subsidiary, Wockhardt USA.
Wockhardt is a Research based and technology intensive global pharmaceutical and biotechnology company. It’s multi-disciplinary and innovative R&D programmes globally, are strongly focused on creating Intellectual Properties. It has 3 research centres globally and manufacturing facilities across India, USA, UK and Ireland.
